EDU 51 - The Role of Radiotherapy in the Management of Non-Malignant Diseases of the Head and Neck
MODERATOR(S)
Richard Bakst, MD - Mount Sinai Health System and New York Proton Center
session DESCRIPTION
The role of radiotherapy in the management of benign diseases is ever expanding. Non-malignant entities of the head and neck are particularly complex and represent thereapuetic challenges given the potential for treatment associated morbidities. Through a multidisciplinary interactive case-based session, our panel will cover four cases that address the following commonly encountered benign tumors of the head and neck for which radiotherapy can offer clinical benefit: 1) Recurrent pleomorphic adenoma 2) Paraganglioma 3) Acoustic neuroma and 4) Desmoid tumors of the neck. For each case, the panel will address appropriate patient selection for definitive or adjuvant radiotherapy as well as focus on dose selection and target volume delineation. Further, we will outline key clinical characteristics for each case that indicate that treatment (over observation) is warranted.
learning objectives
- Determine which patients should be considered for either definitive or adjuvant radiation therapy for the most common benign tumors of the head and neck region.
- Describe appropriate dose regimens and target volume delineation based on the tumor histology and anatomical location.
- Assess clinical characteristics that indicate that treatment rather than observation is warranted.
Credits
| AMA PRA Category 1 Credits: | 1.00 |
Presentations
-
04:00pm - 05:00pm PT
The Role of Radiotherapy in the Management of Non-Malignant Diseases of the Head and Neck
Speaker: Richard Bakst, MD - Mount Sinai Health System and New York Proton Center, NEW YORK -
04:00pm - 04:02pm PT
Introductions
Speaker: Richard Bakst, MD - Mount Sinai Health System and New York Proton Center, NEW YORK -
04:02pm - 04:17pm PT
Dose and Volume Selection for Benign Tumors of the Head and Neck
Speaker: Christopher Wilke, MD, PhD - UPMC Hillman Cancer Center, Pittsburgh -
04:17pm - 04:32pm PT
Patient Selection for Definitive Fractionated or SBRT for Benign Tumors of the Head and Neck
Speaker: Christina Henson, MD - University of Oklahoma Health Sciences Center, Oklahoma City -
04:32pm - 04:47pm PT
Surgical Management of Benign Tumors of the Head and Neck
Speaker: Scott Roof, MD - Icahn School of Medicine at Mount Sinai, New York -
04:47pm - 05:00pm PT
Questions and Answers
Speaker: Richard Bakst, MD - Mount Sinai Health System and New York Proton Center, NEW YORK